{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T18:07:46Z","timestamp":1793642866113,"version":"4.5.1"},"reference-count":54,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100003185","name":"National Psoriasis Foundation","doi-asserted-by":"publisher","award":["851908"],"award-info":[{"award-number":["851908"]}],"id":[{"id":"10.13039\/100003185","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["HL006193-07"],"award-info":[{"award-number":["HL006193-07"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI22\/01847"],"award-info":[{"award-number":["PI22\/01847"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100022654","name":"HudFonden","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100022654","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jidonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Investigative Dermatology"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.jid.2025.03.014","type":"journal-article","created":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T04:50:45Z","timestamp":1747716645000},"page":"2474-2483.e4","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Residual Inflammation in Patients with Psoriasis Treated with Biologic Therapy: Findings from 3 Prospective Observational Cohorts"],"prefix":"10.1016","volume":"145","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-8444-9051","authenticated-orcid":false,"given":"Alba","family":"Lecumberri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0348-5421","authenticated-orcid":false,"given":"Emilio","family":"Berna-Rico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3480-2661","authenticated-orcid":false,"given":"Joel M.","family":"Gelfand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2596-1679","authenticated-orcid":false,"given":"Axel","family":"Svedbom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5587-1204","authenticated-orcid":false,"given":"Carlota","family":"Abbad-Jaime de Arag\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4417-2248","authenticated-orcid":false,"given":"Fernando","family":"Neria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3593-1820","authenticated-orcid":false,"given":"Diana","family":"Monge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6780-0390","authenticated-orcid":false,"given":"Asunci\u00f3n","family":"Ballester-Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9345-0822","authenticated-orcid":false,"given":"Cristina","family":"Pindado-Ortega","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6742-1019","authenticated-orcid":false,"given":"Mar\u00eda","family":"Castellanos-Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1187-1341","authenticated-orcid":false,"given":"Mar","family":"Llamas-Velasco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4290-4721","authenticated-orcid":false,"given":"Maria G.","family":"Barderas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4227-7062","authenticated-orcid":false,"given":"Jorge","family":"Sol\u00eds","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4237-2166","authenticated-orcid":false,"given":"Leticia","family":"Fern\u00e1ndez-Friera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7334-0044","authenticated-orcid":false,"given":"Pedro","family":"Ja\u00e9n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3916-9343","authenticated-orcid":false,"given":"Mona","family":"Stahle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4939-5130","authenticated-orcid":false,"given":"Nehal N.","family":"Mehta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8060-4784","authenticated-orcid":false,"given":"\u00c1lvaro","family":"Gonz\u00e1lez-Cantero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jid.2025.03.014_bib1","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2023-072455","article-title":"Early Detection and Progression of Subclinical Atherosclerosis in Psoriasis (EDSAP): protocol for an observational, single-centre, prospective cohort study","volume":"13","author":"Abbad-Jaime de Arag\u00f3n","year":"2023","journal-title":"BMJ Open"},{"key":"10.1016\/j.jid.2025.03.014_bib2","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1016\/j.jid.2024.02.015","article-title":"Monocyte-to-high-density lipoprotein ratio is associated with systemic inflammation, insulin resistance, and coronary subclinical atherosclerosis in psoriasis: results from 2 observational cohorts","volume":"144","author":"Berna-Rico","year":"2024","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jid.2025.03.014_bib3","doi-asserted-by":"crossref","first-page":"579","DOI":"10.3389\/fimmu.2018.00579","article-title":"Systemic inflammation and cardiovascular comorbidity in psoriasis patients: causes and consequences","volume":"9","author":"Boehncke","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.jid.2025.03.014_bib4","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1161\/CIRCULATIONAHA.115.018381","article-title":"Achievement of dual low-density lipoprotein cholesterol and high-sensitivity C-reactive protein targets more frequent with the addition of ezetimibe to simvastatin and associated with better outcomes in IMPROVE-IT","volume":"132","author":"Bohula","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.jid.2025.03.014_bib5","doi-asserted-by":"crossref","first-page":"197","DOI":"10.18865\/ed.26.2.197","article-title":"Sex and race differences in the relationship between obesity and C-reactive protein","volume":"26","author":"Clark","year":"2016","journal-title":"Ethn Dis"},{"key":"10.1016\/j.jid.2025.03.014_bib6","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.trsl.2016.01.006","article-title":"High-density lipoprotein and inflammation in cardiovascular disease","volume":"173","author":"Connelly","year":"2016","journal-title":"Transl Res"},{"key":"10.1016\/j.jid.2025.03.014_bib7","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.880298","article-title":"Association of inflammatory cytokines with non-alcoholic fatty liver disease","volume":"13","author":"Duan","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.jid.2025.03.014_bib8","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1001\/jamacardio.2019.2589","article-title":"Association of biologic therapy with coronary inflammation in patients with psoriasis as assessed by perivascular fat attenuation index","volume":"4","author":"Elnabawi","year":"2019","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jid.2025.03.014_bib9","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/S0140-6736(09)61717-7","article-title":"C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis","volume":"375","author":"Emerging Risk Factors Collaboration","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.jid.2025.03.014_bib10","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1093\/geronb\/gbaa027","article-title":"Race, gender, and socioeconomic variations in C-reactive protein using the health and retirement study","volume":"76","author":"Farmer","year":"2021","journal-title":"J Gerontol B Psychol Sci Soc Sci"},{"key":"10.1016\/j.jid.2025.03.014_bib11","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1038\/s41591-019-0675-0","article-title":"Chronic inflammation in the etiology of disease across the life span","volume":"25","author":"Furman","year":"2019","journal-title":"Nat Med"},{"key":"10.1016\/j.jid.2025.03.014_bib12","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1001\/jama.296.14.1735","article-title":"Risk of myocardial infarction in patients with psoriasis","volume":"296","author":"Gelfand","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.jid.2025.03.014_bib13","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1001\/jamadermatol.2022.3862","article-title":"Association of apremilast with vascular inflammation and cardiometabolic function in patients with psoriasis: the VIP-A Phase 4, open-label, nonrandomized clinical trial","volume":"158","author":"Gelfand","year":"2022","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jid.2025.03.014_bib14","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1093\/eurjpc\/zwaa033","article-title":"Underperformance of clinical risk scores in identifying imaging-based high cardiovascular risk in psoriasis: results from two observational cohorts","volume":"29","author":"Gonzalez-Cantero","year":"2022","journal-title":"Eur J Prev Cardiol"},{"key":"10.1016\/j.jid.2025.03.014_bib15","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.jid.2021.05.034","article-title":"Subclinical liver disease is associated with subclinical atherosclerosis in psoriasis: results from two observational studies","volume":"142","author":"Gonzalez-Cantero","year":"2022","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jid.2025.03.014_bib16","doi-asserted-by":"crossref","first-page":"H867","DOI":"10.1152\/ajpheart.00774.2016","article-title":"Psoriasis as a human model of disease to study inflammatory atherogenesis","volume":"312","author":"Harrington","year":"2017","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.jid.2025.03.014_bib17","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/nature21363","article-title":"Inflammation, metaflammation and immunometabolic disorders","volume":"542","author":"Hotamisligil","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.jid.2025.03.014_bib18","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.jacc.2005.04.051","article-title":"Race and gender differences in C-reactive protein levels","volume":"46","author":"Khera","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jid.2025.03.014_bib19","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.ahj.2006.02.015","article-title":"Gender and C-reactive protein: data from the Multiethnic Study of Atherosclerosis (MESA) cohort","volume":"152","author":"Lakoski","year":"2006","journal-title":"Am Heart J"},{"key":"10.1016\/j.jid.2025.03.014_bib20","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1038\/jid.2011.365","article-title":"Prevalence of metabolic syndrome in patients with psoriasis: a population-based study in the United Kingdom","volume":"132","author":"Langan","year":"2012","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jid.2025.03.014_bib21","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1161\/CIRCULATIONAHA.116.026859","article-title":"Coronary plaque characterization in psoriasis reveals high-risk features that improve after treatment in a prospective observational study","volume":"136","author":"Lerman","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.jid.2025.03.014_bib22","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/35025203","article-title":"Atherosclerosis","volume":"407","author":"Lusis","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.jid.2025.03.014_bib23","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.1016\/j.jid.2021.10.031","article-title":"Abdominal visceral adiposity is associated with coronary artery plaque lipid-rich necrotic core partly mediated by bone marrow uptake of 18F-FDG positron emission tomography\/computed tomography in psoriasis","volume":"142","author":"Manyak","year":"2022","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jid.2025.03.014_bib24","doi-asserted-by":"crossref","first-page":"A386","DOI":"10.1016\/j.autrev.2011.11.012","article-title":"Geoepidemiology, gender and autoimmune disease","volume":"11","author":"Moroni","year":"2012","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.jid.2025.03.014_bib25","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/j.jid.2023.10.031","article-title":"Association of the complement system with subclinical atherosclerosis in psoriasis: findings from an observational cohort study","volume":"144","author":"Mourino-Alvarez","year":"2024","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jid.2025.03.014_bib26","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.yfrne.2014.04.004","article-title":"Gender differences in autoimmune disease","volume":"35","author":"Ngo","year":"2014","journal-title":"Front Neuroendocrinol"},{"key":"10.1016\/j.jid.2025.03.014_bib27","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.jacc.2012.10.027","article-title":"Low-dose colchicine for secondary prevention of cardiovascular disease","volume":"61","author":"Nidorf","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jid.2025.03.014_bib28","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.jid.2017.07.841","article-title":"Objective measures of psoriasis severity predict mortality: a prospective population-based cohort study [published correction appears in J Invest Dermatol 2018;138:998]","volume":"138","author":"Noe","year":"2018","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jid.2025.03.014_bib29","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/j.jid.2017.10.024","article-title":"Risk of incident liver disease in patients with psoriasis, psoriatic arthritis, and rheumatoid arthritis: a population-based study","volume":"138","author":"Ogdie","year":"2018","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jid.2025.03.014_bib30","doi-asserted-by":"crossref","first-page":"219","DOI":"10.5114\/ada.2016.60615","article-title":"The relationship between body mass index, waist circumference and psoriatic arthritis in the Turkish population","volume":"33","author":"Ozkaya","year":"2016","journal-title":"Postepy Dermatol Alergol"},{"key":"10.1016\/j.jid.2025.03.014_bib31","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.soard.2014.06.010","article-title":"High levels of CRP in morbid obesity: the central role of adipose tissue and lessons for clinical practice before and after bariatric surgery","volume":"11","author":"Paepegaey","year":"2015","journal-title":"Surg Obes Relat Dis"},{"key":"10.1016\/j.jid.2025.03.014_bib32","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1093\/eurheartj\/ehw106","volume":"37","author":"Piepoli","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jid.2025.03.014_bib33","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1093\/eurheartj\/ehw024","article-title":"Residual inflammatory risk: addressing the obverse side of the atherosclerosis prevention coin","volume":"37","author":"Ridker","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jid.2025.03.014_bib34","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1161\/CIRCRESAHA.116.310527","article-title":"How common is residual inflammatory risk?","volume":"120","author":"Ridker","year":"2017","journal-title":"Circ Res"},{"key":"10.1016\/j.jid.2025.03.014_bib35","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1161\/CIRCRESAHA.118.313129","article-title":"Anticytokine agents: targeting interleukin signaling pathways for the treatment of atherothrombosis","volume":"124","author":"Ridker","year":"2019","journal-title":"Circ Res"},{"key":"10.1016\/j.jid.2025.03.014_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.vph.2023.107238","article-title":"Targeting residual inflammatory risk: the next frontier for atherosclerosis treatment and prevention","volume":"153","author":"Ridker","year":"2023","journal-title":"Vascul Pharmacol"},{"key":"10.1016\/j.jid.2025.03.014_bib37","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/S0140-6736(23)00215-5","article-title":"Inflammation and cholesterol as predictors of cardiovascular events among patients receiving statin therapy: a collaborative analysis of three randomised trials","volume":"401","author":"Ridker","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.jid.2025.03.014_bib38","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1056\/NEJMoa042378","article-title":"C-reactive protein levels and outcomes after statin therapy","volume":"352","author":"Ridker","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jid.2025.03.014_bib39","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1056\/NEJMoa1809798","article-title":"Low-dose methotrexate for the prevention of atherosclerotic events","volume":"380","author":"Ridker","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jid.2025.03.014_bib40","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","article-title":"Antiinflammatory therapy with canakinumab for atherosclerotic disease","volume":"377","author":"Ridker","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jid.2025.03.014_bib41","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1056\/NEJMoa021993","article-title":"Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events","volume":"347","author":"Ridker","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jid.2025.03.014_bib42","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.jcmg.2017.08.014","article-title":"Visceral adiposity in psoriasis is associated with vascular inflammation by 18F-Fluorodeoxyglucose positron-emission tomography\/computed tomography beyond cardiometabolic disease risk factors in an observational cohort study","volume":"11","author":"Rivers","year":"2018","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.jid.2025.03.014_bib43","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.jcmg.2017.09.004","article-title":"Psoriasis-related visceral adiposity and arterial inflammation: a new adiposity disease entity?","volume":"11","author":"Schindler","year":"2018","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.jid.2025.03.014_bib44","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.ehj.2014.11.005","article-title":"C-reactive protein, inflammation and coronary heart disease","volume":"67","author":"Shrivastava","year":"2015","journal-title":"Egypt Heart J"},{"key":"10.1016\/j.jid.2025.03.014_bib45","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1161\/STROKEAHA.118.020750","article-title":"SCIL-STROKE (subcutaneous interleukin-1 receptor antagonist in ischemic stroke): a randomized controlled Phase 2 trial","volume":"49","author":"Smith","year":"2018","journal-title":"Stroke"},{"key":"10.1016\/j.jid.2025.03.014_bib46","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1001\/jamadermatol.2024.4433","article-title":"Skin inflammation, systemic inflammation, and cardiovascular disease in psoriasis","volume":"161","author":"Svedbom","year":"2025","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jid.2025.03.014_bib47","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1111\/jdv.19168","article-title":"The psoriasis area and severity index is an independent risk factor for cardiovascular events: a prospective register study","volume":"37","author":"Svedbom","year":"2023","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jid.2025.03.014_bib48","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1056\/NEJMoa1912388","article-title":"Efficacy and safety of low-dose colchicine after myocardial infarction","volume":"381","author":"Tardif","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jid.2025.03.014_bib49","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/j.jaad.2020.12.044","article-title":"Metabolic syndrome and its factors are associated with noncalcified coronary burden in psoriasis: an observational cohort study","volume":"84","author":"Teklu","year":"2021","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jid.2025.03.014_bib50","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.jclinepi.2007.11.008","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"61","author":"von Elm","year":"2008","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.jid.2025.03.014_bib51","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2024.103577","article-title":"Global prevalence of obesity in patients with psoriasis: an analysis in the past two decades","volume":"23","author":"Wang","year":"2024","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.jid.2025.03.014_bib52","first-page":"146","article-title":"Association of obesity and psoriasis: a ten years systematic review","volume":"10","author":"Wardani","year":"2024","journal-title":"J Adv Res Med Health Sci"},{"key":"10.1016\/j.jid.2025.03.014_bib53","first-page":"422","article-title":"High-sensitivity C-reactive protein is a strong predictor of non-alcoholic fatty liver disease","volume":"61","author":"Yeniova","year":"2014","journal-title":"Hepatogastroenterology"},{"key":"10.1016\/j.jid.2025.03.014_bib54","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/j.jhep.2010.12.017","article-title":"C-reactive protein levels in relation to various features of non-alcoholic fatty liver disease among obese patients","volume":"55","author":"Zimmermann","year":"2011","journal-title":"J Hepatol"}],"container-title":["Journal of Investigative Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X2500377X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X2500377X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T01:21:45Z","timestamp":1790817705000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022202X2500377X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":54,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["S0022202X2500377X"],"URL":"https:\/\/doi.org\/10.1016\/j.jid.2025.03.014","relation":{},"ISSN":["0022-202X"],"issn-type":[{"value":"0022-202X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Residual Inflammation in Patients with Psoriasis Treated with Biologic Therapy: Findings from 3 Prospective Observational Cohorts","name":"articletitle","label":"Article Title"},{"value":"Journal of Investigative Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jid.2025.03.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Society for Investigative Dermatology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}